UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$5.06B |
| 2 |
NVIDIA
NVDA
|
+$4.08B |
| 3 |
Apple
AAPL
|
+$3.12B |
| 4 |
UBS Group
UBS
|
+$2.63B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.03B |
Top Sells
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$3.98B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.37B |
| 4 |
Linde
LIN
|
+$916M |
| 5 |
Prologis
PLD
|
+$877M |
Sector Composition
| 1 | Technology | 35.35% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Camden Property Trust
CPT
$11.6B
| $17M | ﹤0.01% |
155,443
-589,475
| -79% | -$64.3M |
|
927
Asbury Automotive
ABG
$4.77B
| $16.8M | ﹤0.01% |
121,368
+15,344
| +14% | +$2.13M |
|
928
Middleby
MIDD
$6.8B
| $16.8M | ﹤0.01% |
137,302
+45,647
| +50% | +$5.6M |
|
929
BCE
BCE
$22.1B
| $16.7M | ﹤0.01% |
+514,609
| New | +$16.7M |
|
930
Coca-Cola Consolidated
COKE
$10.6B
| $16.7M | ﹤0.01% |
153,520
+103,160
| +205% | +$11.2M |
|
931
Timken Company
TKR
$5.39B
| $16.6M | ﹤0.01% |
207,272
+93,105
| +82% | +$7.46M |
|
932
DT Midstream
DTM
$10.8B
| $16.6M | ﹤0.01% |
233,244
+95,871
| +70% | +$6.81M |
|
933
Nextracker
NXT
$10B
| $16.5M | ﹤0.01% |
352,368
+225,892
| +179% | +$10.6M |
|
934
Imperial Oil
IMO
$47.3B
| $16.4M | ﹤0.01% |
+240,226
| New | +$16.4M |
|
935
Meritage Homes
MTH
$5.49B
| $16.4M | ﹤0.01% |
202,156
+89,486
| +79% | +$7.24M |
|
936
Roivant Sciences
ROIV
$9.53B
| $16.3M | ﹤0.01% |
1,544,225
+399,797
| +35% | +$4.23M |
|
937
Range Resources
RRC
$8.36B
| $16.3M | ﹤0.01% |
486,700
+149,584
| +44% | +$5.02M |
|
938
Applied Industrial Technologies
AIT
$9.92B
| $16.3M | ﹤0.01% |
84,078
+36,336
| +76% | +$7.05M |
|
|
CHX
939
DELISTED
ChampionX
CHX
| $16.3M | ﹤0.01% |
490,002
-30,082
| -6% | -$999K |
|
940
Teva Pharmaceuticals
TEVA
$21.7B
| $16.3M | ﹤0.01% |
1,000,849
-1,222,615
| -55% | -$19.9M |
|
941
SPDR Gold Trust
GLD
$116B
| $16.2M | ﹤0.01% |
+75,539
| New | +$16.2M |
|
942
Brookfield Asset Management
BAM
$93.3B
| $16.2M | ﹤0.01% |
+426,658
| New | +$16.2M |
|
943
Procore
PCOR
$10.7B
| $16.2M | ﹤0.01% |
244,754
+115,467
| +89% | +$7.66M |
|
944
Glaukos
GKOS
$4.62B
| $16.2M | ﹤0.01% |
137,019
+70,155
| +105% | +$8.3M |
|
945
Zymeworks
ZYME
$1.21B
| $16.2M | ﹤0.01% |
1,902,401
+1,846,100
| +3,279% | +$15.7M |
|
|
GAP
946
The Gap, Inc.
GAP
$8.88B
| $16.2M | ﹤0.01% |
676,745
+210,128
| +45% | +$5.02M |
|
947
Commercial Metals
CMC
$6.54B
| $16.1M | ﹤0.01% |
291,974
+114,447
| +64% | +$6.29M |
|
948
Kinross Gold
KGC
$28.3B
| $16M | ﹤0.01% |
+1,927,828
| New | +$16M |
|
949
iShares Core S&P Small-Cap ETF
IJR
$85.7B
| $16M | ﹤0.01% |
+150,000
| New | +$16M |
|
950
Iovance Biotherapeutics
IOVA
$821M
| $16M | ﹤0.01% |
1,994,500
+1,814,650
| +1,009% | +$14.6M |
|